D
ysfunction of endothelial cells may promote abnormal vascular growth, such as that found in atherosclerosis and arteriosclerosis, including hypertensive complications. From this viewpoint, we have focused on the role of angiogenic growth factors, such as vascular endothelial growth factor and basic fibroblast growth factor in endothelial cells. In addition, we and others have identified that hepatocyte growth factor (HGF) is also a member of angiogenic growth factors. [1] [2] [3] [4] These angiogenic growth factors induce the proliferation and migration of endothelial cells, remodeling of the extracellular matrix, and the formation of capillary tubules. 5 HGF is a multifunctional cytokine possessing a wide spectrum of biological activities. It is secreted by cells of mesenchymal origin and acts as a mitogen, dissociation factor, and motility factor for many epithelial cells in culture 6 -8 through its tyrosine kinase receptor, c-met. 9 We reported that HGF linking to c-met acts as a protective factor against endothelial cell death induced by serum-free treatment or high glucose conditions. 10 -12 Various intracellular signaling pathways have been shown to be activated by tyrosine kinases linked to c-met. 13 The biological responses mediated by c-met are triggered by the tyrosine phosphorylation of a single multifunctional docking site located in the carboxy-terminal tail of the receptor. 14 This sequence, containing 2 phosphotyrosines, interacts with several cytoplasmic signal transducers either directly or indirectly through molecular adapters such as Grb2, Shc, and Gab1. 15, 16 It has been reported that after HGF stimulation, c-met binds and activates phosphatidylinositol-3-OH (PI3) kinase and recruits the Grb-SOS complex, stimulating the Ras-mitogen-activated protein (MAP) kinase cascade. [17] [18] [19] Although HGF has an antiapoptotic action under serum-free conditions through extracellular signal-related kinase (ERK) activation, 12 the critical signal pathways for cell proliferation and the antiapoptotic effect of HGF are still largely unknown. Therefore, we focused on the signal transduction pathway of HGF in human aortic endothelial cells.
Methods

Cell Culture
Human aortic endothelial cells (passage 3) were obtained from Clonetics Corp and cultured in modified MCDB131 medium supplemented with 5% FCS, 50 g/mL gentamicin sulfate, 50 ng/mL amphotericin B, 10 ng/mL epidermal growth factor, and 1 mmol/L hydrocortisone in the standard fashion. 20 Cells were incubated at 37°C in a humidified atmosphere of 95% air/5% CO 2 with medium changes every 2 days. These cells showed the specific characteristics of endothelial cells by immunohistochemical examination and morphological observation. Briefly, human aortic endothelial cells tested positively for factor VIII antigen and for uptake of diacetylated LDL. All the cells were used within passages 5 to 8.
Measurement of DNA Synthesis as Assessed by Thymidine Incorporation
Endothelial cells in growth medium were equally seeded into 24-well culture plates. The next day, the growth medium was changed to medium supplemented with 0.5% FCS. On day 3 after seeding, 1 hour before the addition of HGF, inhibitors were added to each well of the culture plate, and then the medium was changed to fresh serum-free medium containing HGF (100 ng/mL) or vehicle, and the plate was incubated for 36 hours. Twelve hours before harvest, 
Western Blotting
Western blotting was performed for analysis of ERK, Akt, and signal transducers and activators of transcription (STAT)3 by using a phosphospecific antibody as previously described. 12 After treatment, the cells were extracted with lysis buffer (50 mmol/L Tris-Cl, 2.5 mmol/L EGTA, 1 mmol/L EDTA, 10 mmol/L NaF, 1% deoxycorticosterone, 1% Triton X-100, 1 mmol/L phenylmethylsulfonyl fluoride, and 2 mmol/L Na 3 VO 4 
c-fos Promoter Assay
Endothelial cells were seeded in 6-well plates and transfected with c-fos-luciferase reporter gene (p2FTL) by using lipofectAMINE PLUS (GIBCO-BRL) as previously described. 21 The fos-luciferase reporter gene consists of 2 copies of the c-fos 5Ј-regulated enhancer element (Ϫ357 to Ϫ276), the herpes simplex virus thymidine kinase gene promoter (Ϫ200 to ϩ70), and the luciferase gene. 22 At 24 hours after transfection, transfected cells were incubated with serum-free medium for 24 hours. Quiescent cells were treated with 100 ng/mL HGF for 4 hours, washed with PBS, and lysed for 15 minutes with 500 L cell lysis buffer at room temperature. Then, 10 L cell extract was mixed with 100 L luciferase assay reagent, and the light produced was measured for 30 seconds with use of a luminometer.
LDH Release
The extent of cell death was assessed by using a kit (Wako) to measure released LDH activity from dead cells, because loss of cell membrane integrity was observed in both necrotic and apoptotic cells. 23 After subconfluence was attained, the medium was changed to serum-free medium. The next day, the medium was changed to fresh serum-free medium containing HGF or vehicle.
Activity of Caspase-3 Protease
Cells were harvested after exposure to HGF (100 ng/mL) or vehicle for the indicated periods of time, washed 3 times with PBS, and then suspended in buffer containing 50 nmol/L Tris-HCl (pH 7.4), 1 mmol/L EDTA, and 10 mmol/L EGTA. After addition of 10 mol/L digitonin, cells were incubated at 37°C for 10 minutes.
Lysates were centrifuged at 900g for 3 minutes, and the resulting supernatants (40 g protein) were incubated with 50 mol/L enzyme substrate Ac-DEVD-MCA at 37°C for 1 hour. The level of released 7-amino-4-methylcoumarin was measured by use of a spectrofluorometer (Hitachi F-3000 or F-2000) with excitation at 380 nm and emission at 460 nm. Excitation and emission slit widths were adjusted to 10 and 20 mm, respectively.
Materials
Human recombinant HGF was purified from the culture medium of Chinese hamster ovary cells or C-127 cells, which were transfected with an expression plasmid containing human HGF cDNA. 7 Human recombinant tumor necrosis factor (TNF)-␣ was obtained from Peprotech. PD98059, a specific inhibitor of MAP kinase kinase (MEK), was obtained from New England BioLabs; wortmannin and trichloroacetic acid were obtained from Sigma Chemical Co; and LY-294002 was obtained from Calbiochem.
Statistical Analysis
All values are expressed as meanϮSEM. ANOVA with a subsequent Bonferroni/Dunnett test was used to determine the significance of differences in multiple comparisons. Values of PϽ0.05 were considered statistically significant.
Results
Effect of HGF on ERK (Thr202/Tyr204) and Akt (Ser473) Phosphorylation
The ERK pathway, which is activated by growth factors, is involved in mediating cellular proliferation, transformation, and differentiation. Consistent with previous reports, 12 ERK was phosphorylated from 5 minutes after the addition of HGF, and maximal tyrosine phosphorylation was detected at 15 minutes ( Figure 1A , PϽ0.01), whereas total ERK proteins were not altered by treatment with HGF. In contrast, the protein kinase Akt serves as a multifunctional regulator of cell survival, growth, and glucose metabolism. 24 With respect to its cardiovascular function, Akt acts downstream of vascular endothelial growth factor 25 to confer endothelial cell survival and ensure proper blood vessel development. 26 Nevertheless, there is no report about Akt phosphorylation induced by recombinant HGF (rHGF). As shown in Figure  1B , Akt was also phosphorylated 5 minutes after the addition of rHGF (PϽ0.01).
Role of Phosphorylation of ERK or Akt in Mitogenic Activity of HGF
Therefore, in the present study, we further examined how ERK and Akt act in the mitogenic action of HGF. In previous reports, treatment with PD98059, a MEK inhibitor, significantly attenuated endothelial cell growth induced by rHGF in a dose-dependent manner. 4, 12 Consistent with the previous reports, treatment with PD98059 (30 mol/L) significantly attenuated DNA synthesis induced by rHGF as assessed by thymidine incorporation (Figure 2 , PϽ0.01), whereas rHGF (100 ng/mL) significantly increased thymidine incorporation. In contrast, we also examined the effect of 2 structurally unrelated PI3 kinase inhibitors, wortmannin and LY-294002, on cell proliferation induced by HGF. Wortmannin is a fungal metabolite that has been characterized as a specific inhibitor of PI3 kinase at nanomolar concentrations. 27, 28 LY-294002 is another specific inhibitor of PI3 kinase at low micromolar concentrations, but it has no inhibitory effect against a number of intracellular serine/threonine or tyrosine kinases at a concentration of 50 mol/L. 29, 30 As shown in Figure 2 , pretreatment with both wortmannin (100 nmol/L) and LY-294002 (50 mol/L) could not attenuate the increase in DNA synthesis induced by rHGF as assessed by thymidine incorporation. These results demonstrated that HGF stimulated endothelial growth through ERK rather than Akt phosphorylation. In addition, STAT activity has been reported to be regulated predominantly by phosphorylation on specific tyrosine residues, which causes the STATs to dimerize. STAT dimerization is usually followed by translocation into the nucleus. 31 Within the nucleus, STATs recognize and bind to consensus DNA binding sites that represent enhancer sequences for a variety of genes, including immediate early growth response genes, such as c-fos. Because previous studies have demonstrated that HGF increases STAT3 activity in hepatocytes and epithelial cells, 32 we examined the phosphorylation of STAT3 (Thy705 and Ser727) induced by rHGF in human endothelial cells. As shown in Figure 3A , treatment with rHGF significantly increased the phosphorylation of STAT3 (Ser727), whereas total STAT3 proteins were not altered by treatment with rHGF. However, unexpectedly, rHGF did not affect the phosphorylation of STAT3 (Thy705). Of importance, pretreatment with PD98059, but not wortmannin or LY-294002, significantly attenuated the phosphorylation of STAT3 (Ser727) induced by rHGF ( Figure 3B ). Phosphorylation of STAT3 by HGF was further confirmed by the observation that HGF increased luciferase activity driven by sis-inducible element and serum response element (Figure 4) , inasmuch as the proto-oncogene c-fos is well known to be induced by STAT3. Of importance, pretreatment with PD98059, but not wortmannin or LY-294002, also significantly attenuated the increase in luciferase activity induced by rHGF (Figure 4 , PϽ0.01).
Role of Phosphorylation of ERK or Akt in Antiapoptotic Action of HGF
Because a signaling pathway from PI3 kinase to Akt is implicated in some cellular responses of PI3 kinase, including protection from apoptosis, 33, 34 we next examined the role of ERK and Akt in the antiapoptotic action of HGF. Our previous report documented that HGF inhibited cell death under serum-free conditions, as assessed by LDH release. 12 In the present study, we used TNF-␣ stimulation as another cell death condition. Similar to the serum-free condition, the addition of TNF-␣ significantly increased LDH release (Figure 5A, PϽ0.01) . TNF-␣ stimulation also significantly increased caspase-3 activity as a specific index of apoptosis in a time-dependent manner ( Figure 5B, PϽ0.01) . Interestingly, treatment with rHGF significantly attenuated the caspase-3 activation induced by TNF-␣ stimulation ( Figure 5B , PϽ0.01). Of importance, pretreatment with PI3 kinase inhibitors, wortmannin and LY-294002, but not PD98059 significantly attenuated the decrease in caspase-3 activity induced by rHGF ( Figure 5C, PϽ0.01) . These results indicate that the Akt pathway is critical in the antiapoptotic action of HGF as assessed by caspase-3 activity.
Discussion
Vascular structure has been postulated to be determined in large part by the balance between cell growth and cell death by apoptosis. This process of vascular remodeling plays an important role in determining the natural history of vascular disease. 35 It has become increasingly clear that the process of cell death by apoptosis is a relatively ubiquitous phenomenon observed in a variety of cell types, including endothelial cells. Because HGF, an angiogenic growth factor, may play a pivotal role in the regulation of endothelial cell growth, we explored the signal transduction system of HGF in endothelial cells. In the present study, we demonstrated that HGF significantly increased DNA synthesis and cell proliferation through the ERK pathway, inasmuch as a MEK inhibitor, PD98059, inhibited the increase in DNA synthesis induced by HGF. Unexpectedly, the Akt pathway seems not to contribute to DNA synthesis induced by HGF.
Recently, a new class of SH2 domain-containing signaling molecules has been found to be involved in mediating the growth-promoting activity of other growth factors, such as platelet-derived growth factor and epidermal growth factor. 36 These signaling molecules belong to a family of latent cytoplasmic transcription factors known as STAT. Interestingly, the induction of epithelial tubules by HGF was depen- dent on activation of the STAT pathway. 32 Moreover, c-met, the HGF tyrosine receptor, can bind and directly phosphorylate STAT3. 16, 32 As discussed earlier, STAT proteins are transcription factors that bind specific DNA elements with high affinity for a modified form of the sis-inducible element, which is part of the c-fos gene promoter. Importantly, the present study demonstrated that HGF phosphorylated STAT3 (Ser727) and activated the c-fos promoter in human endothelial cells, whereas a MEK inhibitor inhibited STAT3 (Ser727) phosphorylation and completely blocked activation of the c-fos promoter induced by rHGF. In contrast, PI3 kinase inhibitors did not inhibit this. From these results, ERK may regulate cell growth at the transcription level of an early response gene, such as c-fos, mediated by STAT3 (Ser727) activation in endothelial cells. Unexpectedly, STAT3 (Thy705) was not phosphorylated by the addition of rHGF in human endothelial cells, but it was phosphorylated in epithelial cells. Phosphorylation of STAT at different sites might affect the physiological response in various cells after HGF stimulation.
In contrast, in the present study, inhibitors of PI3 kinase could attenuate the antiapoptotic effect of HGF under TNF-␣ stimulation. Thus, the present study revealed that HGF exerted an antiapoptotic action through the PI3 kinase-Akt pathway rather than the ERK-STAT3 pathway. We speculate that the ERK pathway might be necessary to maintain endothelial cells and that the Akt pathway might be more critical in protection against stress injury. Recent studies have shown that Akt downstream from angiogenic growth factors functions to promote endothelial cell survival, 24, 37 NO synthesis, 38 migration, 39 and cellular responses, which contribute to new blood vessel growth and stabilization of the vascular network. Akt downstream from the signal transduction system of HGF is probably involved in the potent angiogenic activity and antiapoptotic action of HGF. Nevertheless, the Akt pathway might not be involved in endothelial growth, because the inhibitors of PI3 kinase did not affect phosphorylation of STAT3 or activation of the c-fos promoter. HGF may use different signal molecules in its mitogenic activity and antiapoptotic action in human endothelial cells.
Overall, the present study demonstrated that HGF stimulated cell proliferation through the ERK-STAT3 pathway and had an antiapoptotic action through the PI3 kinase-Akt pathway in human aortic endothelial cells. These findings provide new perspectives in the role of HGF in cardiovascular disease, including hypertension, and may explain the preeminent role of HGF in angiogenesis. 
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.01 vs HGF 0 and TNF-␣ (ϩ). B, Fold increase in caspase-3 activity after treatment with TNF-␣ and HGF stimulation compared with serum-free conditions in human endothelial cells. There were 6 per group calculated from 6 independent experiments. TNF-␣ indicates endothelial cells treated with recombinant TNF-␣ (5 ng/mL) under serum-free conditions; HGF, endothelial cells treated with rHGF (100 ng/mL) under serum-free conditions; and TNF-␣ϩHGF, endothelial cells treated with recombinant TNF-␣ (5 ng/mL) and rHGF (100 ng/mL) under serum-free conditions. *PϽ0.01 vs TNF-␣. C, Effect of MEK inhibitor, PD98059, and PI3 kinase inhibitors, wortmannin and LY-294002, on caspase-3 activity induced by rHGF in human endothelial cells. There were 6 per group calculated from 6 independent experiments. Control indicates endothelial cells maintained under serum-free conditions; HGF, endothelial cells treated with rHGF (100 ng/mL) under serumfree conditions; PD, pretreatment (1 hour) with PD98059 (30 mol/L) before addition of rHGF (100 ng/mL) under serum-free conditions; WT, pretreatment (1 hour) with wortmannin (100 nmol/L) before addition of rHGF (100 ng/mL) under serum-free conditions; and LY, pretreatment (1 hour) with LY-294002 (50 mol/L) before addition of rHGF (100 ng/mL) under serum-free conditions. *PϽ0.01 vs control; §PϽ0.01 vs HGF.
